Skip to main content
. 2023 Sep 25;14:1263726. doi: 10.3389/fphar.2023.1263726

TABLE 3.

16 types of anti-tuberculosis drug resistance in two groups of patients.

Drug sensitivity Initially treated patient (n = 102) Retreated patients (n = 293) Total (%) χ2 P
Drug resistance Rate (%) Drug resistance Rate (%)
Ciprofloxacin 8 7.8 29 9.9 37 (9.4) 0.376 0.054
Amikacin 1 1.0 3 1.0 4 (1.0) 0.000 1.000
Capreomycin 2 2.0 4 1.4 6 (1.5) 0.000 1.000
Propylthioisoniazid 47 46.1 185 63.1 232 (58.7) 9.087 0.003
Isoniazid Aminosalicylate Tablets 16 15.7 26 8.9 42 (10.6) 3.695 0.055
Moxifloxacin 17 16.7 68 23.2 85 (21.5) 1.917 0.166
Clarithromycin 11 10.8 27 9.2 38 (9.6) 0.242 0.623
Rifabutin 4 3.9 33 11.3 37 (9.4) 4.803 0.028
Ethambutol 4 3.9 19 6.5 23 (5.8) 0.906 0.341
Isoniazid 16 15.7 72 24.6 88 (22.3) 3.451 0.063
Rifampicin 7 6.9 51 17.4 58 (14.7) 6.714 0.010
Streptomycin 19 18.6 74 25.3 93 (23.5) 1.847 0.174
Levofloxacin 9 8.8 26 8.9 35 (8.9) 0 0.988
Ofloxacin 14 13.7 61 20.8 75 (19.0) 2.475 0.116
Linezolid 6 5.9 22 7.5 28 (7.1) 0.303 0.582
Gatifloxacin 7 6.9 16 5.5 23 (5.8) 0.271 0.603